Photo caption: please provide required caption text if image of employee or specific unknown element. Photo caption: please provide required caption text if image of employee or specific unknown element. Photo caption: please provide required caption text if image of employee or specific unknown element. Photo caption: please provide required caption text if image of employee or specific unknown element. Photo caption: please provide required caption text if image of employee or specific unknown element. Photo caption: please provide required caption text if image of employee or specific unknown element. Photo caption: please provide required caption text if image of employee or specific unknown element.

People

Pre-title text goes here. Pre-title text goes here.

Local Cambridge STEM program empowers next generation of female scientists

Sub title text goes here. Sub title text goes here. Sub title text goes here. Sub title text goes here.Sub title text goes here.

Bristol Myers Squibb Home / Our stories / People / Local Cambridge STEM program empowers next generation of female scientists
May 23, 2022     

Hypertrophic cardiomyopathy (HCM) is a chronic, inheritable disease where there is excessive thickening of the heart muscle. The most frequent cause of HCM is the presence of mutations in sarcomere protein genes. In its progressive form, HCM can lead to serious complications, including increased risk for atrial fibrillation, stroke, heart failure, and in rare cases, sudden cardiac death.

The comprehensive program brings together the unique offerings of Team Rubicon, a nonprofit organization that serves communities by mobilizing military veterans to respond to natural disasters and humanitarian crises, and the Patient Advocate Foundation, a national nonprofit organization that provides case management services and financial aid to patients with chronic, life-threatening and debilitating illnesses. “COVID-19-related food insecurity among immunocompromised patients, who are unable to leave their homes for risk of exposure, is a critical need that is growing increasingly urgent,” said John Damonti, president, the Bristol Myers Squibb Foundation.

LVOT becomes blocked or has reduced blood flow

LVOT becomes blocked or has reduced blood flow

“With this program, we were able to quickly bring together two unique organizations, each with a specialized capability, to create a comprehensive emergency food assistance response for patients.” This program is the latest in the assistance response for patients.” This program is the latest in the Foundation’s COVID-19 relief efforts that have spanned more than 30 countries and five continents around the world — and counting. In each initiative, the Foundation is driven by its mission to address the areas of highest unmet need among the most vulnerable populations in our communities. Its efforts have spanned providing urgent relief, basic human needs and support for patients and front-line workers in regions most severely impacted by COVID-19.


Roland Chen, MD

Senior Vice President and Head, Cardiovascular Development, Global Drug Development



Roland and his team oversee late-stage development of potential medicines for patients with cardiovascular conditions, applying the strong foundation of research and insights generated through years of cardiovascular (CV) experience within the company. 

Roland’s bio

Subscribe to our email newsletter
 

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore 

Subscribe

With this program, we were able to quickly bring together two unique organizations, each with a specialized capability, to create a comprehensive emergency food assistance response for patients.
John Damonti, president, Bristol Myers Squibb Foundation

Hypertrophic cardiomyopathy (HCM)

 

This program is the latest in the Foundation’s COVID-19 relief efforts that have spanned more than 30 countries and five continents around the world — and counting. In each initiative, the Foundation is driven by its mission to address the areas of highest unmet need among the most vulnerable populations in our communities. Its efforts have spanned providing urgent relief, basic human needs and support for patients and front-line workers in regions most severely impacted by COVID-19.

 
About Bristol Myers Squibb

 

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.

Related articles